Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.


Journal

Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369

Informations de publication

Date de publication:
06 2022
Historique:
received: 13 04 2022
accepted: 17 04 2022
entrez: 23 5 2022
pubmed: 24 5 2022
medline: 25 5 2022
Statut: ppublish

Résumé

Low socioeconomic status has been associated with poor outcomes in patients with atrial fibrillation (AF). However, little is known about socioeconomic disparities in adherence to stroke prevention with direct oral anticoagulants (DOACs). We assessed the hypothesis that AF patients with higher income or educational levels have better adherence to DOACs in terms of treatment implementation and persistence. The used nationwide registry-based FinACAF cohort covers all patients with incident AF starting DOACs in Finland during 2011-2018. The implementation analyses included 74 222 (mean age 72.7 ± 10.5 years, 50.8% female) patients, and persistence analyses included 67 503 (mean age 75.3 ± 8.9 years, 53.6% female) patients with indication for permanent anticoagulation (CHA

Identifiants

pubmed: 35599338
doi: 10.1002/prp2.961
pmc: PMC9124817
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00961

Informations de copyright

© 2022 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.

Références

BMJ Open. 2021 May 31;11(5):e048839
pubmed: 34059516
Med Sci Monit. 2019 Apr 11;25:2649-2657
pubmed: 30971681
Diabetes Res Clin Pract. 2017 Jul;129:1-15
pubmed: 28499162
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005969
pubmed: 32148102
J Pediatr Psychol. 2015 Jan-Feb;40(1):66-74
pubmed: 24648257
Clin Epidemiol. 2021 Jul 19;13:533-554
pubmed: 34321928
Cochrane Database Syst Rev. 2011 Apr 13;(4):CD009094
pubmed: 21491414
Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1367-1377
pubmed: 28752560
Eur Heart J Cardiovasc Pharmacother. 2021 Apr 09;7(FI1):f72-f80
pubmed: 32324233
PLoS One. 2019 Jun 14;14(6):e0217278
pubmed: 31199815
Am J Geriatr Pharmacother. 2008 Dec;6(5):255-63
pubmed: 19161928
Ann Pharmacother. 2016 May;50(5):360-8
pubmed: 26917817
Ann Intern Med. 2007 Jun 19;146(12):857-67
pubmed: 17577005
PLoS One. 2018 Mar 9;13(3):e0194081
pubmed: 29522561
J Am Heart Assoc. 2022 Mar 15;11(6):e024119
pubmed: 35229612
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Gen Hosp Psychiatry. 2022 Jan-Feb;74:88-93
pubmed: 34999528
Front Pharmacol. 2018 Dec 03;9:1353
pubmed: 30559661
Heart. 2020 Jan;106(2):119-126
pubmed: 31601729
Korean Circ J. 2019 Oct;49(10):883-907
pubmed: 31535493
Mult Scler Relat Disord. 2016 Jul;8:78-85
pubmed: 27456879
SSM Popul Health. 2021 Sep 07;15:100915
pubmed: 34527804
Expert Rev Cardiovasc Ther. 2018 Nov;16(11):857-873
pubmed: 30293472
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):269-276
pubmed: 34677571
Eur J Epidemiol. 2022 Jan;37(1):95-102
pubmed: 34985732
J Manag Care Spec Pharm. 2018 May;24(5):440-448
pubmed: 29694286
Res Pract Thromb Haemost. 2019 Oct 24;4(1):141-153
pubmed: 31989096
Heart Fail Rev. 2013 Jul;18(4):409-27
pubmed: 22723048
Stroke. 1991 Aug;22(8):983-8
pubmed: 1866765
Pharmacol Res Perspect. 2022 Jun;10(3):e00961
pubmed: 35599338
PLoS One. 2021 Jan 15;16(1):e0245610
pubmed: 33450744
Ann Intern Med. 2018 Jul 3;169(1):30-35
pubmed: 29946690
Int J Equity Health. 2021 Feb 10;20(1):58
pubmed: 33568126
Eur Heart J. 2012 Nov;33(21):2719-47
pubmed: 22922413
BMJ. 2020 Feb 24;368:m693
pubmed: 32094110
Europace. 2020 Apr 1;22(4):547-557
pubmed: 31598651
Lancet. 2017 Apr 8;389(10077):1475-1490
pubmed: 28402829
Eur Heart J. 2021 Oct 21;42(40):4126-4137
pubmed: 34269375
Eur Heart J Qual Care Clin Outcomes. 2021 Oct 28;7(6):574-582
pubmed: 32735316
PLoS One. 2021 Mar 18;16(3):e0248134
pubmed: 33735259

Auteurs

Konsta Teppo (K)

University of Turku, Turku, Finland.

Jussi Jaakkola (J)

University of Turku, Turku, Finland.
Heart Unit, Satakunta Central Hospital, Pori, Finland.

Fausto Biancari (F)

Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
Clinica Montevergine, GVM Care & Research, Mercogliano, Italy.

Olli Halminen (O)

Department of Industrial Engineering and Management, Aalto University, Espoo, Finland.

Miika Linna (M)

Aalto University, Espoo, Finland.
University of Eastern Finland, Kuopio, Finland.

Jari Haukka (J)

University of Helsinki, Helsinki, Finland.

Jukka Putaala (J)

Neurology, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.

Paula Tiili (P)

University of Helsinki, Helsinki, Finland.

Ossi Lehtonen (O)

Aalto University, Espoo, Finland.

Mikko Niemi (M)

University of Helsinki, Helsinki, Finland.

Pirjo Mustonen (P)

Heart Center, Turku University Hospital, Turku, Finland.

Janne Kinnunen (J)

Neurology, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.

Juha Hartikainen (J)

University of Eastern Finland, Kuopio, Finland.
Heart Center, Kuopio University Hospital, Kuopio, Finland.

K E Juhani Airaksinen (KEJ)

University of Turku, Turku, Finland.
Heart Center, Turku University Hospital, Turku, Finland.

Mika Lehto (M)

Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
University of Helsinki, Helsinki, Finland.
Department of Internal Medicine, Lohja Hospital, Lohja, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH